Get the Stockscreener App
2.94
6.91%
0.19
After Hours:
2.96
0.02
+0.68%
Absci Corp stock is traded at $2.94, with a volume of 870.61K.
It is up +6.91% in the last 24 hours and down -27.76% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$2.75
Open:
$2.81
24h Volume:
870.61K
Relative Volume:
0.84
Market Cap:
$315.85M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-2.4098
EPS:
-1.22
Net Cash Flow:
$-70.76M
1W Performance:
+9.70%
1M Performance:
-27.76%
6M Performance:
-30.17%
1Y Performance:
+111.51%
1-Day Range:
$2.80
$3.02
1-Week Range:
$2.52
$3.02
52-Week Range:
$1.35
$6.72
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.94 | 315.85M | 4.21M | -97.67M | -70.76M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference - Yahoo Finance
Absci Co. (NASDAQ:ABSI) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Portland InnoA founder's return | Absci heads to Europe - The Business Journals
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care - Benzinga
Generative AI vs. cancer: Absci partners with Memorial Sloan Kettering for new therapeutics - MSN
HC Wainwright Has Negative Outlook of Absci FY2024 Earnings - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q3 2024 Earnings Call Transcript - Insider Monkey
FMR LLC Acquires Significant Stake in Absci Corp - GuruFocus.com
Absci Corporation Advances AI-Driven Drug Development - TipRanks
Absci earnings missed by $0.05, revenue fell short of estimates - Investing.com South Africa
Absci Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results - Yahoo Finance
Earnings Scheduled For November 12, 2024 - Benzinga
Absci Corp (ABSI) Q3 2024 Earnings Report Preview: What to Look For - GuruFocus.com
Absci (ABSI) Set to Announce Earnings on Tuesday - Defense World
4 Biotech Stocks With AI, Machine Learning Prowess - Investing.com
Absci to Host R&D Day on December 12, 2024 - Yahoo Finance
I: Exploring 🧭 TechBio - substack.com
Absci (ABSI) Scheduled to Post Earnings on Tuesday - MarketBeat
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI - Yahoo Finance
Absci Co. (NASDAQ:ABSI) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Absci to Participate in Upcoming Investor Conferences - Yahoo Finance
You might want to take a look at Absci Corp (ABSI) now - SETE News
Market Recap: Absci Corp (ABSI)’s Negative Momentum, Closing at 3.98 - The Dwinnex
Absci (ABSI) Price Target Increased by 21.21% to 6.80 - MSN
Absci Corp (ABSI)’s stock rises to 4.10 per share - US Post News
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024 - Yahoo Finance
Absci Corp [ABSI] Insider Activity: An Update for Investors - Knox Daily
Is Absci (NASDAQ:ABSI) The Best AI Penny Stock to Buy for 2025? - Insider Monkey
Absci Corp (ABSI) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Absci Corp [ABSI] stock for 98,892 USD was sold by Jonasson Zachariah - Knox Daily
PHLX Housing Index (HGX) QuotePress Release - The Globe and Mail
Bank of Montreal Can Takes Position in Absci Co. (NASDAQ:ABSI) - Defense World
Bank of Montreal Can Invests $527,000 in Absci Co. (NASDAQ:ABSI) - MarketBeat
1 'Strong Buy' Penny Stock To Invest In AI Drug Development - Barchart
10 Trending AI Stocks in October - Insider Monkey
The Potential Rise in the Price of Absci Corp (ABSI) following insiders activity - Knox Daily
Insider’s View: Deciphering Absci Corp (ABSI)’s Financial Health Through Ratios - The Dwinnex
ABSI (Absci Corp) has impressive results - US Post News
Absci Co. (NASDAQ:ABSI) Shares Acquired by Squarepoint Ops LLC - MarketBeat
Can Absci Corp Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
Absci Corp [ABSI] Records 200-Day SMA of $4.33 - Knox Daily
Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile (ABSI) - Seeking Alpha
Guggenheim initiates Buy on Absci stock, cites AI breakthroughs in biologics - Investing.com Canada
How did Absci Corp (ABSI) fare last session? - US Post News
Absci (NASDAQ:ABSI) Coverage Initiated at Guggenheim - MarketBeat
Top 5 AI & Digital Biotech Companies (November 2024) - Securities.io
Monitoring Absci Corp (ABSI) after recent insider movements - Knox Daily
Market Update: Absci Corp (ABSI) Sees Negative Movement, Closing at 3.97 - The Dwinnex
There is no doubt that Absci Corp (ABSI) ticks all the boxes. - SETE News
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Absci Corp Stock (ABSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
| Redmile Group, LLC | Director |
Mar 01 '24 |
Buy |
4.50 |
222,222 |
999,999 |
8,253,316 |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):